IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Ukrainian Society of Regional Anesthesia and Pain Therapy
Memorial Sloan Kettering Cancer Center
Ain Shams University
University of Arkansas
Hospices Civils de Lyon
Hospital Universitari de Bellvitge
Institut Bergonié
Fudan University
Columbia University
Rijnstate Hospital
Institut Paoli-Calmettes
Instituto do Cancer do Estado de São Paulo
University Health Network, Toronto
Radboud University Medical Center
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
University of Leipzig
Baptist Health South Florida
Johns Hopkins University
University of Aarhus
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Aarhus
Seoul National University Hospital
Peking University Cancer Hospital & Institute
Sun Yat-sen University
Blokhin's Russian Cancer Research Center
Karolinska University Hospital
Tenwek Hospital
Chinese University of Hong Kong
Asan Medical Center
First People's Hospital of Hangzhou
Beth Israel Deaconess Medical Center
Oslo University Hospital
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
E-DA Hospital
First People's Hospital of Hangzhou
Amsterdam UMC, location VUmc
Seoul National University Hospital
Seoul National University Hospital
Instituto do Cancer do Estado de São Paulo
Sun Yat-sen University
Southwest Hospital, China
Chinese University of Hong Kong
Institut Bergonié
Guangxi Medical University
Guangxi Medical University
Massachusetts General Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute